SermorelinSMO2

Images are illustrative. Actual specifications are as selected and confirmed in writing.

Growth Hormone & IGF-1

Sermorelin

GH-related growth

Sermorelin specifications and reference prices. Select a specification to add it to your cart.

2mg/vial x 10vials
Reference priceTemporarily sold out

For laboratory research only. Not for human or veterinary use.

COA 检测报告 / Reports

Compare all specifications & reference prices
SKUSpecification / packReference price (USD)
SMO22mg/vial x 10vialsTemporarily sold out
SMO55mg/vial x 10vialsUS$154.55
SMO1010mg/vial x 10vialsUS$248.48

Temporarily sold-out specifications can still be added to an inquiry to ask about restocking. An inquiry is not an order or an agreed price.

RESEARCH FOCUS

Main Uses & FAQs

This page organizes directly related information on Sermorelin regarding GH-related growth. First, look at research questions and findings, then verify the population or species, study formulations, and scope of interpretation.

Main TopicsGH-related growth
USAGE REFERENCE

Sermorelin · Usage reference (for research purposes)

The following presents common research-context references for reconstitution, storage, dosage and cycles. The following presents common references in research settings. This page does not constitute advice for use in humans or animals.

🧪Reconstitution

Suggested Diluent
Bacteriostatic Water (containing 0.9% benzyl alcohol); some peptides may use sterile water or acetic acid to aid dissolution. See the individual product descriptions.
Diluent Volume
Slowly introduce the diluent along the vial wall until the lyophilized powder is covered. A common example is 5 mg reconstituted with 2 mL of bacteriostatic water, yielding approximately 2.5 mg/mL. Referenced reconstitution volumes are approximately 1–2.5 mL, with 2 mL commonly used. It is suggested to select and record a fixed volume based on the COA supplied with the purchase.
Handling Notes
Introduce the diluent slowly along the vial wall rather than directly onto the lyophilized powder. Leave it for 60–90 seconds to dissolve naturally; do not shake vigorously.

💾Storage

Unreconstituted Lyophilized Powder
Refrigerate at 2–8°C, protected from light; avoid repeated freeze–thaw cycles.
After Reconstitution
Refrigerate at 2–8°C; a common recommendation is touse within 28 days; do not freeze.
Transport
For short periods, use insulated packaging with ice packs; avoid high temperatures and direct light.

📏Dosage Reference (Research)

Purpose / SettingCommon Reference
ReferenceCommonly used 100–300mcg/day before bedtime

🔁Cycle

Subcutaneous injection before sleep.

View the Complete Usage Guide Library →

Note: The above describes common research-context references, rather than clinical recommendations. Refer to the batch COA and research protocol. For research use only; not for human or animal use.

Research SummaryKey Findings

What research findings does Sermorelin have regarding GH-related growth?

Average growth rate increased from 4.8 to 7.2 cm/year. Other studies report: most subjects' growth rate improved, and partial growth indicators in higher dose groups were close to GH group.[1] ↗ [2] ↗

Before ReadingStudy populations, species, formulations and delivery conditions each have a defined scope. Research on an ingredient does not establish that this site's product batches have been validated for efficacy in humans or veterinary use.
3 Main ReferencesSorted by First Publication Date ↓
Human Study1994 · Historical basic researchREF. 01

What was observed in the children's growth rate study?

Research Findings

Average growth rate increased from 4.8 to 7.2 cm/year.[1] ↗

Study Design

18 children with idiopathic short stature; 12 months

Scope & Limitations

1994; short-term speed changes cannot be equated to final adult height benefits.

View the Article Title and Full Citation+

Treatment with GHRH(1-29)NH2 in children with idiopathic short stature induces a sustained increase in growth velocity.

Kirk JM, Trainer PJ, Majrowski WH, Murphy J, Savage MO, Besser GM.

Clinical endocrinology · Volume and issue year 1994
First published 1994-10-01 · PMID 7955460.
DOI 10.1111/j.1365-2265.1994.tb02580.x

Human Study1993 · Historical basic researchREF. 02

How should studies comparing GH in children’s growth be interpreted?

Research Findings

Most subjects showed increased growth rate, with some growth indicators in the higher dose group approaching those in the GH group.[2] ↗

Study Design

43 children with hypothalamic GH deficiency; randomized comparison

Scope & Limitations

1993; specific deficiencies in children, not for adult anti-aging purposes.

View the Article Title and Full Citation+

Growth response to growth hormone-releasing hormone(1-29)-NH2 compared with growth hormone.

Neyzi O, Yordam N, Ocal G, Bundak R, Darendeliler F, Açikgöz E, Berberoğlu M, Günöz H, Saka N, Calikoğlu AS.

Acta Paediatrica (Oslo, Norway: 1992). Supplement · Volume/Issue, 1993
First published 1993-03-01 · PMID 8329826.
DOI 10.1111/j.1651-2227.1993.tb12828.x

Human Study1990 · Historical basic researchREF. 03

What findings are there in growth follow-up of one-year-old children?

Research Findings

The significance of research promoting linear growth shown in one-year follow-up.[3] ↗

Study Design

Children who are short in stature and have slow growth; continuous subcutaneous administration

Scope & Limitations

1990 Old paper; specific results need to be combined with the original research conditions.

View the Article Title and Full Citation+

Continuous subcutaneous GHRH(1-29)NH2 promotes growth over 1 year in short, slowly growing children.

Brain CE, Hindmarsh PC, Brook CG.

Clinical endocrinology · Volume and issue year 1990
First published 1990-02-01 · PMID 2140733.
DOI 10.1111/j.1365-2265.1990.tb00851.x

i

Currently, 3 original studies related to the theme of this page have been selected. The number of studies includes different designs, populations, or preparations, not commercial clinical efficacy ratings. This page is a usage-oriented positive data selection, not a systematic review or dosing recommendation. Historical studies, combination preparations, and special models are all separately indicated.

GO DEEPER

What Questions Do These Studies Address?

Compare study populations, findings and scope.

↗
QUESTIONS, ANSWERED

Sermorelin · Frequently Asked Questions.

What research findings does Sermorelin have regarding GH-related growth?+

Average growth rate increased from 4.8 to 7.2 cm/year. Other studies report: most subjects' growth rate improved, and partial growth indicators in higher dose groups were close to GH group.[1] ↗ [2] ↗

Are Sermorelin growth studies applicable to adults?+

The classic data on this page mainly come from children who are short or have slow growth. Short-term growth improvement in children cannot directly be extrapolated to adult height increase, anti-aging, or ultimate adult height benefits.[1] ↗ [3] ↗

Sermorelin—these conclusions apply to which study populations?+

18 children with idiopathic short stature; 12 months; 43 hypothalamic-derived GH-deficient children; randomized comparison; short stature and slow-growing children; continuous subcutaneous administration. 1994; short-term growth rate change doesn't equal final adult height benefit.[1] ↗ [2] ↗ [3] ↗

VENTRO PEPTIDES & BIOTECH · RESEARCH PRODUCT RETAIL

Research peptides. Shop by product.

Compare specifications, reference prices and COA reports. Add products to your cart to request a quote.

Ventro Peptides & Biotech Logo
QUALITY DOCUMENTSCOA BY PRODUCTGLOBAL DELIVERYTECHNICAL SUPPORT

01 / CATALOG

Browse products

7 products Product names, specifications, and prices follow the current quotation
SemaglutideSM10COA

Images are illustrative. Actual specifications are as selected and confirmed in writing.

GLP-1 & Metabolic Research

Semaglutide

10mg/vial x 10vials

US$90.91
TirzepatideTR20COA

Images are illustrative. Actual specifications are as selected and confirmed in writing.

GLP-1 & Metabolic Research

Tirzepatide

20mg/vial x 10vials

US$160.61
RetatrutideRT10COA

Images are illustrative. Actual specifications are as selected and confirmed in writing.

GLP-1 & Metabolic Research

Retatrutide

10mg/vial x 10vials

US$109.09
BPC157BC10COA

Images are illustrative. Actual specifications are as selected and confirmed in writing.

Repair & Recovery Research

BPC157

10mg/vial x 10vials

US$133.33
MOTS-CMS20COA

Images are illustrative. Actual specifications are as selected and confirmed in writing.

Longevity & Mitochondrial Research

MOTS-C

20mg/vial x 10vials

US$257.58
LiraglutideLR10COA

Images are illustrative. Actual specifications are as selected and confirmed in writing.

GLP-1 & Metabolic Research

Liraglutide

10mg*10vials

US$164.71
IGF-lr3IG1COA

Images are illustrative. Actual specifications are as selected and confirmed in writing.

Growth Hormone & IGF-1

IGF-lr3

1mg/vial x 10vials

US$505.88

03 / ABOUT VENTRO

Reliable peptide supply, built for long-term partnerships.

Ventro supports research product retail purchases with clear pack specifications, available quality documents, and responsive international support.

  • High-purity peptides
  • Available COA reports
  • COA & quality documentation
  • Flexible small-quantity purchases
  • Reliable global fulfillment
  • Research product retail support

04 / QUALITY SYSTEM

Quality without compromise

Browse the available COA reports by product. Confirm documentation for your order with our team.

Controlled quality workflowRaw material to final release
Responsive global supportProduct matching and technical support

RESEARCH PRODUCT INQUIRY

Submit a product inquiry

Tell us the product, specification, and expected quantity. Our team will respond with pricing and available documents.

Use another email app

Opening an inquiry creates a draft, not a sent message. Review and press Send in Gmail, WhatsApp or your email app. Opening a channel passes the draft to the chosen provider. Privacy & cookies

Contact Ventro

Choose a channel to contact the Ventro team directly.

Use another email app

Opening an inquiry creates a draft, not a sent message. Review and press Send in Gmail, WhatsApp or your email app. Opening a channel passes the draft to the chosen provider. Privacy & cookies

WhatsApp